Predictive Biomarkers for PD-1 Axis Therapies: The Hidden Treasure or a Call for Research. - Wikidata - awgldk - TriplyDB

Predictive Biomarkers for PD-1 Axis Therapies: The Hidden Treasure or a Call for Research.

Predictive Biomarkers for PD-1 Axis Therapies: The Hidden Treasure or a Call for Research.

http://www.wikidata.org/entity/Q37083326

about

PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial Platforms.Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy.PD-L1 testing, fit for routine evaluation? From a pathologist's point of view.Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies.High-throughput genomic profiling of tumor-infiltrating leukocytes.Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy.PD-L1 immunohistochemistry for non-small cell lung carcinoma: which strategy should be adopted?Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition

P2860

Q37481946-2A0F849B-CAD6-4923-9048-81C3D763BFE1 Q37718376-1C35A534-632A-4317-8802-BACA4D286C34 Q38774259-EF34E981-C756-428A-9000-FE25C1AC34D0 Q38874383-7F259A88-68B4-4F57-8C6A-FDFC7D73F29D Q38884388-0F9642AA-645B-44C4-A679-68047D8FED60 Q41167610-27E3FE72-0A22-4A2E-A1F7-A1A9B10B2083 Q48620065-973B5C34-F1ED-4A15-B22D-E447A2F68080 Q58806091-4AD6C81F-7F6E-45F5-BCBC-D2E59B646B97

P2860

Predictive Biomarkers for PD-1 Axis Therapies: The Hidden Treasure or a Call for Research.

http://www.wikidata.org/entity/Q37083326

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 March 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Predictive Biomarkers for PD-1 ...... easure or a Call for Research.

@en

Predictive Biomarkers for PD-1 ...... easure or a Call for Research.

@nl

type

label

Predictive Biomarkers for PD-1 ...... easure or a Call for Research.

@en

Predictive Biomarkers for PD-1 ...... easure or a Call for Research.

@nl

prefLabel

Predictive Biomarkers for PD-1 ...... easure or a Call for Research.

@en

Predictive Biomarkers for PD-1 ...... easure or a Call for Research.

@nl

P1433

Q37083326-A29E7FCF-7A5D-4846-9C77-6AF7385B7E5C

P1476

Q37083326-C1DEE8B0-5FDA-4FD3-824A-94A737E09655

P2093

Q37083326-AE50F0DC-545D-4C19-BC61-04CF7C92E1F8

P2860

Q37083326-2313A7A4-36BA-488F-AFE6-97CAA879977C

Q37083326-2C3F3F11-83F1-4C71-B072-890B65D5807D

Q37083326-3C89B1AE-65F3-4225-9833-47472AFE4A08

Q37083326-51E66B5A-F480-4699-9BA6-A077AE88A233

Q37083326-5FAF4F6A-3650-4145-A980-FD581C361CEE

Q37083326-607A4530-D33F-4138-8D90-E49C01FB098F

Q37083326-78303ABA-E903-49CF-9550-B16DC79432A8

Q37083326-820C565A-A31A-4E26-8E00-4DDEA2E1BEF6

Q37083326-A5A59958-F3B4-46D2-BAC7-A4DAE7F8637D

Q37083326-C245D535-B9C3-4B90-AED8-8BA2ECDEC54F

P304

Q37083326-0EBE04CA-2E37-4F00-805C-2E7421AA5562

P31

Q37083326-72655422-2C96-4E4C-9268-61584113B9B1

P356

Q37083326-26D6CF3D-C0FB-42BE-8148-C4E74437ECC6

P407

Q37083326-2D1F1AB5-78F6-4352-A2C0-C3098F751CAF

P433

Q37083326-84B69FBE-188C-4FC3-9ABE-74903638765F

P478

Q37083326-A829FA06-35C4-44A6-BC42-D62DCF6AFF25

P50

Q37083326-0BA6CE81-4421-44BD-917B-95A03312437C

Q37083326-B48EE6E6-4BC7-49C1-94B3-9C775EEC774B

P577

Q37083326-6772C40E-ABA9-4631-9083-9B3900CCABF5

P698

Q37083326-C0256602-016B-460C-9249-FE67408E73F0

P921

Q37083326-D39EF17D-DDCD-44C7-8F6D-1D5D04EC74FD

P932

Q37083326-FF40C38D-AECB-41EC-8620-02FA314203BA

P356

1078-0432.CCR-16-0169

P1433

Clinical Cancer Research

P1476

Predictive Biomarkers for PD-1 ...... easure or a Call for Research.

@en

P2093

Edward Kaftan

http://www.w3.org/2001/XMLSchema#string

P2860

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy

Nivolumab in previously untreated melanoma without BRAF mutation

PD-1 blockade induces responses by inhibiting adaptive immune resistance

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

The prognostic landscape of genes and infiltrating immune cells across human cancers

Molecular and genetic properties of tumors associated with local immune cytolytic activity.

P304

2102-2104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-16-0169

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Kurt A Schalper

P577

2016-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26957559

http://www.w3.org/2001/XMLSchema#string

P921

P932

4940186

http://www.w3.org/2001/XMLSchema#string